Applied BioCode announced today that Beth Laderman has been appointed as their new Chief Scientific Officer signaling a significant step in the company’s expansion. With 25 years of experience in.
Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States
U.S. Distribution of the Automated High Throughput Multiplex Molecular. | May 8, 2023
Hardy Diagnostics will begin offering Applied BioCode's MDx-3000 molecular diagnostic system, tests, and analyte specific reagents to US hospitals and reference laboratories.